Gall Matthew

EDGAR CIK 0001816194

Iteos Therapeutics, Inc. - ITOS

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CFO
Chief Financial Officer
Direct Buys
1
$38,635
5,000 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/19/2024
11/19/2024
Buy
5,000 @ $7.73
 $38,635 65,429 (8.27%) Direct